Back to CVE records
Medium 6.5Published Sep 4, 2026

CVE-2026-85621LobeChat 2.2.1 Webhook Signature Verification Bypass QQ Feishu

Updated under an hour ago ()

Does this affect you?

It affects lobehub. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

LobeChat (LobeHub) 2.2.1 does not properly verify inbound chat-platform webhook signatures in the QQ and Feishu adapters. The webhook route (/api/agent/webhooks/:platform) is unauthenticated by design and delegates verification to each adapter; the QQ adapter performs no Ed25519 signature verification on dispatched message events, and the Feishu adapter only performs an optional static-token comparison that is skipped when no token is configured (the default) and is not a body signature. An unauthenticated attacker who knows the public webhook URL can POST forged inbound messages with an attacker-chosen sender identity and arbitrary text, causing the bot owner's agent to process attacker-controlled input and treat the attacker as a trusted platform sender.

CVSS
6.5 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
Weakness (CWE)
CWE-345
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
VulnCheck
NVD analysis
Deferred
Record last updated
Sep 8, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
lobehub lobehub
lobehub:lobehub (from the name)
through 2.2.15
CNA record

References

  • issue-tracking
  • product
  • technical-description
  • technical-description
  • third-party-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.